Economy
Best Hospitals for Thymus Cancer Worldwide
According to the American Association of Oncologists, thymus cancer is rare and accounts for about 0.5% of all tumors. The illness does not show any signs at the initial stage but, at the same time, has a high potential for malignancy. It is characterized by rapid growth and metastasis.
Over the years, we have accumulated statistics on the leading hospitals in Europe and the US for treating thymus cancer. And we can recommend to patients exactly where they will be treated most effectively. So keep reading, and we will share with you the necessary information.
Criteria for selecting the best hospitals for thymus cancer
Not only an error-free diagnosis and the results of further treatment but sometimes life itself depends on the correct choice of the treatment center and attending physician. Therefore, it is necessary to collect all possible information in order not to be disappointed in the chosen hospital in the future:
- Hospitals specialization. It is essential in the treatment of advanced cases of thymus cancer.
- It is necessary to look at clinic articles, scientific developments, and the introduction of various treatment methods for thymus cancer.
- Information about oncologists and thoracic surgeons who work in this hospital.
- It would be good to get acquainted with the reviews of specialists in this field but not working in this clinic.
- It is advisable to choose several hospitals and compare them.
- The second opinion is an opportunity to verify the accuracy of the diagnosis, to hear an alternative point of view of an experienced specialist, or to learn about alternative treatment options.
Finding a hospital with the online service AiroMedical is fast, simple, and effective. It is enough to specify the doctor’s specialty or the disease’s symptoms in the search bar to find the right specialist. Then, in a few seconds, the system will provide you with a relevant list of the hospitals.
Top hospitals for thymus cancer treatment in the United States
University Hospitals Michigan Ann Arbor
Langone Hospital New York
Wisconsin University Hospitals Madison
Benefits of Medical Treatment in the US
Several essential advantages of the list of hospitals in the US:
- Reliable diagnosis, the accuracy of which determines the choice of a treatment plan and the effectiveness of the procedures.
- Hybrid operating rooms, the latest microsurgical and minimally invasive operations equipment.
- World-class thoracic surgeons who are proficient in all modern methods.
Top hospitals for thymus cancer treatment in Europe
University Hospital Frankfurt, Germany
Marien Hospital Marl, Germany
Teknon Medical Centre, Spain
Anadolu Medical Centre, Turkey
Benefits of medical treatment in Europe
European medicine offers the most current opportunities for timely thymus cancer detection and comprehensive diagnosis. Treatment in hospitals in Europe is also:
- World leadership in the number of scientific papers and discoveries in medicine.
- Use of unique developments and author’s methods.
- Careful monitoring of compliance with international standards at all stages of manipulation.
Top hospitals for thymus cancer treatment in Poland
Medicover Hospital Warsaw
European Health Center Otwock
Gamma Knife Exira Center Katowice
Benefits of medical treatment in Poland
Advantages of Polish cancer treatment:
- Fast and accurate examination, low-traumatic technologies.
- Complex treatment, including thymus surgery, chemo, and radiotherapy.
- Remote consultations with doctors after completion of therapy.
Top hospitals for thymus cancer treatment in Italy
University Hospital San Raffaele Milan
European Oncology Institute Milan
Agostino Gemelli University Policlinic Rome
Benefits of medical treatment in Italy
A whole list of hospitals in Italy has such advantages:
- The best doctors with extensive experience treating thymus tumors.
- Diagnostics are carried out on innovative equipment that provides 100% accuracy of results.
- Healthcare costs are more affordable than in America, and the quality is not inferior.
Top hospitals for thymus cancer treatment in Germany
Helios Clinic Berlin-Buch
University Hospital Charite
University Hospital Heidelberg
Benefits of medical treatment in Germany
Several advantages of hospitals in Germany:
- Hybrid operating rooms, robot-assisted surgery.
- Close cooperation of German thoracic surgeons with many narrow specialists.
- Pediatric thoracic surgeons and oncologists are at the disposal of young patients.
Best thymus cancer doctors worldwide
The best doctors in thymus cancer treatment:
Prof. Dr. med. Maximilian Bockhorn
Dr. med. habil. Krzysztof Wrobel
Prof. Dr. Thomas Vogl
Prof. Dr. Hans Hoffmann
Prof. Dr. Helmut Friess
Best treatment solutions for treating thymus cancer
Doctors of the best hospitals in the US and Europe treat thymus cancer using conservative methods and surgically, taking advantage of the latest oncology achievements that allow achieving success in more than 90% of cases. You can read more about each treatment method for thymus cancer on our website.
Here we will mention only a few:
- Da Vinci’s robotic thymectomy. Minimally invasive surgery through four small incisions for the video camera and the robot’s “hands.” The system provides an accurate 3D image of the operating field and the accuracy of movements inaccessible to humans.
- Ablation. A needle-like electrode is inserted into the patient, and an electric current is applied. It leads to a local increase in tissue temperature and the destruction of cancer cells.
- Brachytherapy. It is the irradiation of the tumor with radioactive isotopes from the inside. Unique seeds with an active substance are injected directly into the cancer tissue with the help of endoscopic equipment.
- Targeted therapy. Angiogenesis inhibitors (drugs that prevent the formation of blood vessels) and growth factor inhibitors are most often used.
How to get treatment in the best clinics for thymus cancer
Some diagnoses divide a person’s life into “before” and “after.” You can’t be prepared for them; they sound unfair and scary. Every day in our work, we encounter people tired of endless, fruitless trips to doctors who have almost lost hope of recovery. And how nice it is to see how people’s attitudes to life change after the first positive treatment results.
The AiroMedical project aims to help people who are faced with thymus cancer. On our platform, you will find:
- Consultations of leading oncologists, information about the features of diagnosis and thymus cancer treatment.
- Hospital contacts and appointments for diagnostics and treatment without queues and tedious waiting.
- New therapy methods are used only in a few cancer centers.
Treating thymus cancer with AiroMedical is an opportunity to entrust your health to the best oncologist, constantly improving their professional skills. So leave us a request and get a personalized treatment program.
References
- Semenchuk O. Thymus cancer treatment. AiroMedical. Updated January, 2023. https://airomedical.com/search/thymus-cancer-tymoma
- Kyiashko D. Thymus cancer guide. AiroMedical. Updated March 22, 2023. https://airomedical.com/blogs/disease-guides/thymus-cancer-guide
- Yuan Z., Gao S., Mu J., Xue Q., Mao Y. Long-term outcomes of 307 patients after complete thymoma resection. National library of medicine. Published May 15, 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/
By Adedapo Adesanya
Five securities pulled down the NASD Over-the-Counter (OTC) Securities Exchange by 1.72 per cent on Friday, August 14, cutting the market capitalisation by N47.04 billion to N2.689 trillion from N2.727 trillion, and slicing the NASD Security Index (NSI) by 78.37 points to 4,465.83 from 4,532.03 points.
11 Plc led the price decliners yesterday after its price went down by N15.03 to N230.00 per share from N245.03 per share. MRS Oil Plc weakened by N13.20 to N118.80 per unit from N132.00 per unit, Central Securities Clearing System (CSCS) Plc slid by N10.30 to N99.46 per share from N109.76 per share, Okitipupa Plc fell by N6.99 to N270.01 per unit from N277.00 per unit, and Afriland Properties Plc dipped by N2.00 to N20.00 per share from N22.00 per share.
Business Post reports that the OTC securities exchange recorded four gainers during the session, led by FrieslandCampina Wamco Nigeria Plc, which appreciated by N9.85 to N169.85 per unit from N160.00 per unit. IPWA Plc gained 70 Kobo to close at N10.41 per share versus N9.71 per share, Industrial and General Insurance (IGI) Plc rose by 4 Kobo to 54 Kobo per unit from 50 Kobo per unit, and Geo-Fluids Plc improved by 1 Kobo to N2.06 per share from N2.05 per share.
The volume of trades soared by 64.8 per cent to 3.2 million units from the previous session’s 1.9 million units, the value of transactions jumped by 78.2 per cent to N375.7 million from N210.8 million, and the number of deals surged by 35.3 per cent to 46 deals from 34 deals.
Great Nigeria Insurance (GNI) Plc was the most traded stock by value on a year-to-date basis, with 3.4 billion units valued at N8.4 billion, followed by Infrastructure Credit Guarantee (Infracredit) Plc with 2.3 billion units sold for N6.5 billion, and CSCS Plc with 79.0 million units exchanged for N5.7 billion.
GNI Plc also closed the day as the most traded stock by volume on a year-to-date basis, with 3.4 billion units worth N8.4 billion, followed by Infracredit Plc with 2.3 billion units transacted for N6.5 billion, and Resourcery Plc with 1.1 billion units traded for N415.7 million.
By Dipo Olowookere
The dominance of the bears on the Nigerian Exchange (NGX) Limited was consolidated on Friday, after further inflicting an 0.12 per cent loss at the close of trading activity.
All the key sectors of the local stock market turned red yesterday as a result of sustained profit-taking, though the industrial goods space was flat.
The insurance counter lost 1.49 per cent, the energy index shed 0.63 per cent, the consumer goods segment declined by 0.46 per cent, and the banking sector tumbled by 0.23 per cent.
Consequently, the All-Share Index (ASI) retreated by 398.18 points to 242,619.20 points from 243,017.38 points, and the market capitalisation receded by N257 billion to N156.624 trillion from N156.881 trillion.
Fortis Global Insurance lost 9.31 per cent to trade at N2.63, Omatek depreciated by 9.04 per cent to N1.51, John Holt slipped by 9.00 per cent to N9.10, RT Briscoe slumped by 7.94 per cent to N11.60, and Dangote Sugar went down by 7.79 per cent to N64.55.
But International Energy Insurance gained 9.92 per cent to sell for N5.32, Trans-Nationwide Express appreciated by 9.65 per cent to N2.84, Guinea Insurance improved by 6.67 per cent to 80 Kobo, Regency Alliance grew by 6.25 per cent to 85 Kobo, and Japaul jumped by 5.36 per cent to N2.95.
The market breadth index remained negative, with 30 price losers and 21 price gainers, indicating weak investor sentiment.
The level of activity contracted yesterday, with the trading volume, value, and number of deals down by 66.67 per cent, 10.65 per cent, and 5.60 per cent, respectively.
This was because market participants transacted 1.4 billion shares worth N45.3 billion in 39,134 deals during the session compared with the 4.2 billion shares valued at n50.7 billion traded in 41,454 deals on Thursday.
Fortis Global Insurance was the most active equity for the day, with a turnover of 874.1 million units valued at N2.4 billion, Cornerstone Insurance sold 100.3 million units worth N506.5 million, Universal Insurance traded 56.7 million units for N44.5 million, Sterling Holdings exchanged 53.3 million units worth N402.9 million, and MTN Nigeria transacted 44.6 million units valued at N31.4 billion.
By Adedapo Adesanya
The Naira maintained stability against the United States Dollar in the different segments of the foreign exchange (FX) market on Friday, August 14, according to data obtained by Business Post.
At the Nigerian Autonomous Foreign Exchange Market (NAFEM), the local currency remained unchanged at N1,357.65/$1, but lost N6.05 against the Pound Sterling to trade at N1,840.10 versus the previous session’s N1,834.05/£1, and depreciated against the Euro by N4.70 to sell for N1,571.70/€1 compared with the preceding day’s N1,567.00/€1.
At the black market, the Nigerian currency traded flat against the Dollar at N1,395/$1, but gained N3 at the GTBank forex desk to quote at N1,364/$1 versus Thursday’s exchange rate of N1,367/$1.
Data from the Central Bank of Nigeria (CBN) showed that interbank FX transactions surged by 51.2 per cent to $119.594 million from $79.097 million. These transactions were executed in 137 deals, higher than the 98 deals recorded a day earlier.
FX inflows from exporters, remittances and other sources, alongside demand from importers and individuals requiring Dollars, continue to shape market conditions.
Meanwhile, the cryptocurrency market recovered yesterday after experiencing a downturn in the previous sessions following reports that index provider MSCI has proposed new “non-operating company” screens for its Global Investable Market Indexes. Although the framework does not explicitly target cryptocurrency, it evaluates whether a company’s core operating assets constitute more than 50 per cent of its total holdings.
Heavy digital asset treasury adopters, including Strategy and Metaplanet, fail the proposed criteria and face potential removal during upcoming index rebalancings. While inclusion in major equity benchmarks previously allowed passive index funds and ETFs to automatically acquire these stocks, their removal could trigger forced institutional selling.
Dogecoin (DOGE) grew by 0.7 per cent to $0.07, Binance Coin (BNB) expanded by 0.6 per cent to $611.34, Ethereum (ETH) added 0.4 per cent to trade at $1,879.65, and Bitcoin (BTC) increased by 0.2 per cent to $63,045.87, with Ripple (XRP), the US Dollar Tether (USDT), and the US Dollar Coin (USDC) flat at $1.00, respectively.
But Cardano (ADA) lost 1.2 per cent to trade at $0.1795, TRON (TRX) shed 0.4 per cent to finish at $0.3323, and Solana (SOL) declined by 0.2 per cent to $75.60.
